STABILIZED NEEDLE ELECTRODE SYSTEM FOR IN-VIVO GLUCOSE MONITORING BASED ON OPEN FLOW MICROPERFUSION

Citation
Gp. Rigby et al., STABILIZED NEEDLE ELECTRODE SYSTEM FOR IN-VIVO GLUCOSE MONITORING BASED ON OPEN FLOW MICROPERFUSION, Analyst, 121(6), 1996, pp. 871-875
Citations number
36
Categorie Soggetti
Chemistry Analytical
Journal title
ISSN journal
00032654
Volume
121
Issue
6
Year of publication
1996
Pages
871 - 875
Database
ISI
SICI code
0003-2654(1996)121:6<871:SNESFI>2.0.ZU;2-7
Abstract
Preliminary in vitro studies and in vivo performance of amperometric g lucose needle enzyme electrodes incorporating an open microflow techni que, in which the sensor surface is subjected to a flow of fluid, are reported, Initially using a slow flow (60 mu l h(-1)) of isotonic phos phate buffer over the enzyme electrode tip, an interface was created w hich reduced cellular/protein fouling for electrode measurements in wh ole blood, Here a minor reduction in electrode response (apparent only at high glucose concentration) occurred which was not cumulative and therefore not associated with fouling, The protection afforded by the moving aqueous film was independent of fluid composition; the use of i sotonic/hypertonic buffer, addition of anticoagulant (1% m/v heparin) or enhanced fluid viscosity (addition of 1% v/v glycerol) did not affe ct the system, Implantation of the electrode and its microflow cannula into subcutaneous tissue in rats was associated with a decreased buff er flow (30 mu l h(-1)) and had the effect of (i) reducing electrode s tabilization (30 min), (ii) accelerating 'pick up' of tissue glucose c hanges after intravenous glucose (1-2 min lag) or insulin (3-7 min lag ) and (iii) achieving a correlation between tissue and blood glucose v alues under dynamic conditions (r(2) = 0.98, y = 0.99x + 0.23), Reasse ssment of the electrode response in vitro, following a 4 h monitoring period, provided a sensor response within 3% of the original electrode sensitivity, indicating little or no surface fouling and avoiding the requirement for repeated in vivo calibrations at least over the initi al implantation period.